Legacy Education Alliance, Inc. (LEAI)
OTCQB OTCQB Primary 
Legacy Education: An Underfollowed Compounder Outside The AI Hype
Legacy Education is transitioning from acquisition-driven growth to organic expansion, making Q3 2026 the first quarter that reflects the underlying business. Growth slowed to 15%, but campus expansions, new programs and higher enrollment suggest the long-term growth story remains intact. The stock is no longer deeply undervalued, but I believe its healthy balance sheet, solid profitability, and reasonable valuation still support a Buy rating.
Legacy Education: There's Still Value At The Current Price
Legacy Education's fundamentals have improved significantly, with Q3 revenue up 51% and operating profit up 55%, driven by new programs and an acquisition. The stock trades at a lower P/E than peers (15 times vs 18-20 on average), while growing more, offering further upside if re-rated to industry averages. Risks include ongoing dilution from acquisitions and stock-based compensation, as well as strict regulation in the for-profit education sector.
Legacy Education: Benefiting From The Shortage Of Health Professionals
Legacy Education offers strong growth prospects due to the U.S. healthcare professional shortage and strategic acquisitions for geographic expansion. Legacy has grown 32% annually over five years and 35% during Q1 2025, maintains high EBITDA margins, and holds a clean balance sheet with $20M net cash. Valued at a P/E of only 13, Legacy's potential return is supported by a large market and favorable regulatory environment.
Legacy Education Files For IPO Featuring Growth And Profits
Legacy Education Inc. is seeking $10 million in an IPO, offering in-person advanced education for healthcare-related careers. The company targets early to mid-20-year-olds in Southern to Central California and has strong revenue growth and profitability. Legacy plans to use the IPO's net proceeds for investments at facilities, new programs, and general working capital purposes.
